To explore the phenotypic expression and clinical significance of NETO2 in ESCC progression, we first examined the mRNA and protein level of NETO2 in cancerous specimens compared with paired normal tissues (Figure 1A,B). The gene discussed is NETO2; the disease is esophageal squamous cell carcinoma.